JF
VYGR icon

Jump Financial’s Voyager Therapeutics VYGR Stock Holding History

Jump Financial’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$81.9K Buy
23,387
+2,844
+14% +$10.8K ﹤0.01% 1916
2026
Q1 		$79.3K Sell
20,543
-15,777
-43% -$62.1K ﹤0.01% 1768
2025
Q4 		$143K Buy
+36,320
New +$161K ﹤0.01% 1795
2024
Q4 		– Sell
-10,999
Closed -$64.3K – 2054
2024
Q3 		$64.3K Buy
+10,999
New +$80K ﹤0.01% 1550
2024
Q2 		– Sell
-16,168
Closed -$151K – 2313
2024
Q1 		$151K Buy
+16,168
New +$136K ﹤0.01% 1747
2023
Q2 		– Sell
-16,300
Closed -$126K – 2201
2023
Q1 		$126K Buy
16,300
+5,817
+55% +$46.3K 0.01% 1405
2022
Q4 		$63.9K Sell
10,483
-15,517
-60% -$88.2K ﹤0.01% 1477
2022
Q3 		$154K Sell
26,000
-9,778
-27% -$62.6K 0.01% 1393
2022
Q2 		$211K Sell
35,778
-1,169
-3% -$7.9K 0.01% 1273
2022
Q1 		$281K Buy
36,947
+18,347
+99% +$81.8K 0.01% 1103
2021
Q4 		$50K Buy
+18,600
New +$63.5K ﹤0.01% 1308

Other funds holding VYGR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Jump Financial's VYGR Position: Q2 2026 in Review

Jump Financial increased its Voyager Therapeutics (VYGR) stake by 14% in Q2 2026, buying an estimated $10.8K and bringing the position to 23,387 shares worth $81.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1916.

Jump Financial first reported a position in VYGR in Q4 2021 and has held it in 11 quarters since. The position peaked at $281K in Q1 2022. 135 funds tracked by Wall St. Rank hold VYGR as of Q2 2026.

  • Jump Financial held 23,387 shares of Voyager Therapeutics worth $81.9K as of Q2 2026.
  • Jump Financial bought 2,844 Voyager Therapeutics shares in Q2 2026, an estimated $10.8K.
  • Voyager Therapeutics made up ﹤0.01% of Jump Financial's portfolio in Q2 2026, its #1916 holding.
  • Jump Financial first reported a position in Voyager Therapeutics in Q4 2021 and has held it in 11 quarters since.
  • Jump Financial's Voyager Therapeutics position peaked at $281K in Q1 2022.
  • 135 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.